Primary amoebic meningoencephalitis

	Primary amoebic meningoencephalitis Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Primary Amoebic Meningoencephalitis from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Primary amoebic meningoencephalitis On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Primary amoebic meningoencephalitis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Primary amoebic meningoencephalitis
CDC on Primary amoebic meningoencephalitis
Primary amoebic meningoencephalitis in the news
Blogs on Primary amoebic meningoencephalitis
Directions to Hospitals Treating Primary amoebic meningoencephalitis
Risk calculators and risk factors for Primary amoebic meningoencephalitis

	Primary amoebic meningoencephalitis
	Classification and external resources
	Histopathology of amebic meningoencephalitis due to Naegleria fowleri. Direct fluorescent antibody stain. (CDC)

This page is about clinical aspects of the disease. For microbiologic aspects of the causative organism(s), see Naegleria fowleri.

For patient information, click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and keywords: PAM; PAME; Naegleria fowleri infection; N. fowleri infection; primary amebic meningoencephalitis

Overview


Primary amoebic meningoencephalitis
Classification and external resources
Histopathology of amebic meningoencephalitis due to Naegleria fowleri. Direct fluorescent antibody stain. (CDC)